Completed NA INTERVENTIONAL 6-arm NCT00739752

Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics

Interventions to Increase HBV Vaccinations in STD Clinics

Sponsor: Indiana University

Interventions Gain-Framed-Offered Gain-Framed-Recommended Loss-Framed-Offered Loss-Framed-Recommended Non-Framed-Offered Non-Framed-Recommended

Updated 9 times since 2017 Last updated: Nov 7, 2018 Started: Jun 30, 2003 Primary completion: Jun 30, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hepatitis B Virus and is currently completed. Indiana University leads this study, which shows 9 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Dec 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Dec 2018 [monthly]

Completed NA
Oct 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Oct 2017 [monthly]

Completed NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States
• Indianapolis, United States